I checked it out as soon as you posted it. I'm getting icthy finger again myself, but want to see a couple things happen first. Hope I don't miss anything spectacular!
Really? I didn't exaggerate anything!!! All I did was note the headline i was seeing on the intraday pop. ""We believe that EnteroMedics is about to gain FDA clearance for VBLOC" NOT MY WORDS but THEIRS. Another poster posted the whole story.
To your question "Who are they" Go look for yourself
We get through $1.60 with good volume and it's off to the races in my opinion. That's where I think shorts start covering!
Touting 70% coverage is good. But one might ask why if 70% of consumers are covered why are they not interested in Belviq? I know that's what i'm wondering. And why the lack of refills? Two things i just don't understand and why i'm out for now.
There's a new video out from CNBC that aired this morning during Squawk, Doctors are concerned with the "safety" of these new drugs thanks to the P&F debacle 10+ years ago.. This is not a bash because I know a few people still invested in one of the companies mentioned. I feel for them being their neck deep in the carnage that has happened to the pps over the last year or so. I think we may see a shift from investors rolling out of these companies taking a hard look at ETRM soon. After-all we know the device is safe (much safer than drugs) and works as well if not better than drugs do. The video is in the news section on the Arena board if interested in checking it out.
Doc, what would you attribute to the reasoning for lack of refills being dispensed? Thanks
Just curious because you said "The company is not doing anything even after the panel meeting (surprisingly)." That's just not true. They just attended an investors conference where i would say by the applause people where listening. I have listened in the past on these live events where the room sounded empty. They are continuing work both here in the U.S. as well as overseas. They are busy I assure you and while they wait they are preparing to get this rolled out shortly after approval. Maybe even in talks with someone already about a partnership deal or better. Who knows!!!!
So what would you be saying or doing differently if you where them?
Other than calling people crybabies it's hard to argue with this post. Some may not like Ade for what might seem like lofty projections. His estimates and projections are his which he is entitled too.
I have yet to get back into Arena but found this while doing some research on ETRM.
"Australian researchers have found new weight loss drug Qsymia effective in maintaining or reducing weight, but hard for many patients to tolerate!"
I agree with you it seems a little ridiculous that it's not UP coming off what was an overwhelmingly positive recommendation. I also find it hard to believe ETRM was unnoticed in a market where obesity is front & center stage. If word was not getting out before it is now "I'm seeing it with my own two eyes!"
I think a 100+% gain as you suggested although maybe not what you hoped for is what we can expect on or shortly after approval. I am basing this on nothing more then what we already know from three other companies in the space. I said before, I think we can expect a market cap $300M-$500M as fair value considering this is what the market has suggested. We really have nothing else to base it off of. All three are early stage company/s (Arena-Vivus-Orex) with a play on the obesity space. Mind you two of those companies where once valued at $2B dollars before even hitting the market.
Good news is If approved I believe ETRM gets bought out or signs a partnership deal for ROW minus USA keeping it to themselves. If someone wants all of it they'll have to pay! But what's a $1B to a large company who gets a device with Billions in potential return!? They are BRILLIANTLY setting themselves up for a takeover by someone for the use of Safe & effective device for WW use.
I really do consider it a gift at these levels
We could be closer than we think. I know some disagree but I find it interesting EnteroMedics is already in discussions with the FDA surrounding the label. That's more info then what some other company/s divulge.
Nice find even posted today.
Nice summary. I also get the feeling their looking for some kind of deal for outside the U.S. keeping the U.S. in house. They won't be able to hold this down much longer imo. Approval is almost certain from everything I read and heard.